DNA-based drug to prevent blood clots

Researchers have proposed a side effect-free anticoagulating treatment that has so far proved effective in test mice and could be ready for human trials in just a few years.

Related Keywords

Tokyo ,Japan ,Japanese ,Keitaro Yoshimoto ,Asuka Sakata ,University Of Tokyo ,Nara Medical University ,Associate Professor Keitaro Yoshimoto ,Assistant Professor Asuka Sakata ,Molecular Therapy Nucleic ,Blood Clots ,Anticoagulants ,Heparin ,Heparin Induced Thrombocytopenia ,Thrombin ,Molecular Therapy Nucleic Acids ,Mrna Molecules ,